Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer

MONTREAL, March 7, 2017 -- (Healthcare Sales & Marketing Network) -- Milestone Pharmaceuticals USA, Inc., a clinical stage cardiovascular company, today announced the appointment of Joseph G. Oliveto as President and Chief Executive Officer, effective imm... Biopharmaceuticals, Cardiology, Personnel Milestone Pharmaceuticals, etripamil, paroxysmal supra-ventricular tachycardia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news